Clinical trial
Precision Medicine in Lups Nephritis: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal Biopsy
NCT05358652 is registered in ClinicalTrials.gov with Fundacin Biomedica Galicia Sur as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Precision Medicine in Lups Nephritis: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal Biopsy
- Lead sponsor
- Fundacin Biomedica Galicia Sur
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 15, 2021
- Completion date
- January 15, 2023
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lupus nephritis, systemic lupus erythematosus